Annual Accounts Payable
$953.00 K
-$300.00 K-23.94%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual accounts payable is $953.00 thousand, with the most recent change of -$300.00 thousand (-23.94%) on December 31, 2023.
- During the last 3 years, OCX annual accounts payable has risen by +$521.00 thousand (+120.60%).
- OCX annual accounts payable is now -47.35% below its all-time high of $1.81 million, reached on December 31, 2021.
Performance
OCX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$872.00 K
-$179.00 K-17.03%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly accounts payable is $872.00 thousand, with the most recent change of -$179.00 thousand (-17.03%) on September 30, 2024.
- Over the past year, OCX quarterly accounts payable has dropped by -$264.00 thousand (-23.24%).
- OCX quarterly accounts payable is now -66.25% below its all-time high of $2.58 million, reached on March 31, 2022.
Performance
OCX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
OCX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.9% | -23.2% |
| 3 y3 years | +120.6% | -64.6% |
| 5 y5 years | +474.1% | -64.6% |
OCX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.4% | at low | -66.3% | at low |
| 5 y | 5-year | -47.4% | +120.6% | -66.3% | +101.8% |
| alltime | all time | -47.4% | +825.2% | -66.3% | +541.2% |
OncoCyte Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $872.00 K(-17.0%) |
| Jun 2024 | - | $1.05 M(+15.7%) |
| Mar 2024 | - | $908.00 K(-4.7%) |
| Dec 2023 | $953.00 K(-23.9%) | $953.00 K(-16.1%) |
| Sep 2023 | - | $1.14 M(+29.8%) |
| Jun 2023 | - | $875.00 K(-37.3%) |
| Mar 2023 | - | $1.40 M(+11.3%) |
| Dec 2022 | $1.25 M(-30.8%) | $1.25 M(-31.4%) |
| Sep 2022 | - | $1.83 M(-25.9%) |
| Jun 2022 | - | $2.46 M(-4.6%) |
| Mar 2022 | - | $2.58 M(+42.8%) |
| Dec 2021 | $1.81 M(+319.0%) | $1.81 M(+51.1%) |
| Sep 2021 | - | $1.20 M(+10.1%) |
| Jun 2021 | - | $1.09 M(-0.4%) |
| Mar 2021 | - | $1.09 M(+152.8%) |
| Dec 2020 | $432.00 K(-7.9%) | $432.00 K(-65.8%) |
| Sep 2020 | - | $1.26 M(+8.6%) |
| Jun 2020 | - | $1.16 M(-28.8%) |
| Mar 2020 | - | $1.64 M(+248.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $469.00 K(+182.5%) | $469.00 K(+31.0%) |
| Sep 2019 | - | $358.00 K(-35.6%) |
| Jun 2019 | - | $556.00 K(+308.8%) |
| Mar 2019 | - | $136.00 K(-18.1%) |
| Dec 2018 | $166.00 K(-5.1%) | $166.00 K(-14.4%) |
| Sep 2018 | - | $194.00 K(-16.4%) |
| Jun 2018 | - | $232.00 K(-24.4%) |
| Mar 2018 | - | $307.00 K(+75.4%) |
| Dec 2017 | $175.00 K(-58.5%) | $175.00 K(+15.1%) |
| Sep 2017 | - | $152.00 K(-18.7%) |
| Jun 2017 | - | $187.00 K(-11.4%) |
| Mar 2017 | - | $211.00 K(-50.0%) |
| Dec 2016 | $422.00 K(+48.1%) | $422.00 K(-51.5%) |
| Sep 2016 | - | $870.00 K(+353.1%) |
| Jun 2016 | - | $192.00 K(-52.4%) |
| Mar 2016 | - | $403.00 K(+41.4%) |
| Dec 2015 | $285.00 K(+97.9%) | $285.00 K(+1.1%) |
| Sep 2015 | - | $282.00 K(+95.8%) |
| Dec 2014 | $144.00 K(+39.8%) | $144.00 K |
| Dec 2013 | $103.00 K | - |
FAQ
- What is OncoCyte annual accounts payable?
- What is the all time high annual accounts payable for OncoCyte?
- What is OncoCyte annual accounts payable year-on-year change?
- What is OncoCyte quarterly accounts payable?
- What is the all time high quarterly accounts payable for OncoCyte?
- What is OncoCyte quarterly accounts payable year-on-year change?
What is OncoCyte annual accounts payable?
The current annual accounts payable of OCX is $953.00 K
What is the all time high annual accounts payable for OncoCyte?
OncoCyte all-time high annual accounts payable is $1.81 M
What is OncoCyte annual accounts payable year-on-year change?
Over the past year, OCX annual accounts payable has changed by -$300.00 K (-23.94%)
What is OncoCyte quarterly accounts payable?
The current quarterly accounts payable of OCX is $872.00 K
What is the all time high quarterly accounts payable for OncoCyte?
OncoCyte all-time high quarterly accounts payable is $2.58 M
What is OncoCyte quarterly accounts payable year-on-year change?
Over the past year, OCX quarterly accounts payable has changed by -$264.00 K (-23.24%)